John Danesh
John Danesh
Verified email at
Cited by
Cited by
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
Analysis of protein-coding genetic variation in 60,706 humans
M Lek, KJ Karczewski, EV Minikel, KE Samocha, E Banks, T Fennell, ...
Nature 536 (7616), 285-291, 2016
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age
C Sudlow, J Gallacher, N Allen, V Beral, P Burton, J Danesh, P Downey, ...
PLoS medicine 12 (3), e1001779, 2015
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
Emerging Risk Factors Collaboration
The lancet 375 (9733), 2215-2222, 2010
Genetic studies of body mass index yield new insights for obesity biology
AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ...
Nature 518 (7538), 197-206, 2015
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh, JG Wheeler, GM Hirschfield, S Eda, G Eiriksdottir, A Rumley, ...
New England journal of medicine 350 (14), 1387-1397, 2004
Serious mental disorder in 23 000 prisoners: a systematic review of 62 surveys
S Fazel, J Danesh
The lancet 359 (9306), 545-550, 2002
Prevalence of serious mental disorder in 7000 refugees resettled in western countries: a systematic review
M Fazel, J Wheeler, J Danesh
The lancet 365 (9467), 1309-1314, 2005
Major lipids, apolipoproteins, and risk of vascular disease
ERF Collaboration, E Di Angelantonio, N Sarwar, P Perry, S Kaptoge, ...
JAMA: The Journal of the American Medical Association 302 (18), 1993-2000, 2009
Major lipids, apolipoproteins, and risk of vascular disease
E Di Angelantonio, N Sarwar, P Perry, S Kaptoge, KK Ray, A Thompson, ...
JAMA: The Journal of the American Medical Association 302 (18), 1993-2000, 2009
Discovery and refinement of loci associated with lipid levels
CJ Willer, EM Schmidt, S Sengupta, GM Peloso, S Gustafsson, S Kanoni, ...
Nature genetics 45 (11), 1274, 2013
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies
J Danesh, R Collins, P Appleby, R Peto
Jama 279 (18), 1477-1482, 1998
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Emerging Risk Factors Collaboration
The Lancet 375 (9709), 132-140, 2010
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.
E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ...
Diabetes mellitus, fasting glucose, and risk of cause-specific death
Emerging Risk Factors Collaboration
New England Journal of Medicine 364 (9), 829-841, 2011
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
BF Voight, GM Peloso, M Orho-Melander, R Frikke-Schmidt, M Barbalic, ...
The Lancet 380 (9841), 572-580, 2012
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
J Danesh, P Whincup, M Walker, L Lennon, A Thomson, P Appleby, ...
Bmj 321 (7255), 199-204, 2000
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
Nature genetics 47 (10), 1121-1130, 2015
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
GB Ehret, PB Munroe, KM Rice, M Bochud, AD Johnson, DI Chasman, ...
Nature 478 (7367), 103-109, 2011
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.
AP Morris, BF Voight, TM Teslovich, T Ferreira, AV Segrè, ...
Nature genetics 44 (9), 981-990, 2012
The system can't perform the operation now. Try again later.
Articles 1–20